Archive
Proactive news snapshot: Concepta, Braveheart Investment, Seeing Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:FUM
Futura Medical specialises in the development and global commercialisation of innovative sexual health products, including lead product Eroxon®. The company's core strength lies in its research, development and commercialisation of topically delivered gel formulations in sexual health products.
303 stories · page 11 of 16
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Thursday
The AIM-listed firm said the trial will be a dose ranging, multicentre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically applied glyceryl trinitrate (GNT)
Investments and investor services
Imports in the period fell 2.1%, while exports increased 2.4%
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Wednesday
Futura Medical said the study supports its strong belief that higher dose forms of MED2002 should improve efficacy, particularly in more severe cases
Resource stocks suffer as US dollar makes headway on forex markets
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Wednesday
MED2002 is a rapid onset gel designed for those men where the current pill-based treatments aren’t appropriate, or carry significant side-effects
Investments and investor services
FTSE 100 closed down around six points at 7,132 but big cap miners were up
Previews of results statements from supermarket chain, Morrisons; insurer behemoth, the Pru, and infrastructure contractor, Balfour Beatty
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
The definitive results of the company's pharmacokinetic study will be used to guide phase III clinical assessments of lead product, MED2002
FTSE 100 finished almost 76 points lower at 7,138, while the FTSE 250 lost over 254 points at 19,863.
Archive
The week ahead includes the UK's budget statement and earnings from Morrisons, Prudential, Cairn Energy, Cineworld, Savills, Wetherspoons, Balfour Beatty and Fevertree
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of today's top risers and fallers in London